Overview

Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the subjective and objective effects of Oxymorphone ER (Opana ER) versus Oxycodone CR (Oxycontin).
Phase:
Phase 4
Details
Lead Sponsor:
Endo Pharmaceuticals
Collaborators:
Kendle Early Stage - Toronto
Kendle Early Stages Toronto
Treatments:
Analgesics, Opioid
Hydromorphone
Oxycodone
Oxymorphone